CBT in Adolescents With Type 1 Diabetes

Sponsor
University of Bristol (Other)
Overall Status
Completed
CT.gov ID
NCT00360061
Collaborator
Diabetes UK (Other)
90
1
45
2

Study Details

Study Description

Brief Summary

The effectiveness of cognitive behavioural therapy (CBT) for adolescents with type 1 diabetes will be tested. This structured, time-limited, problem-orientated therapy will be used to impact on psychosocial factors influencing diabetic control, with the patient and therapist working together on specific goals to develop adaptive strategies.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Cognitive Behaviour Therapy
N/A

Detailed Description

Ninety 11-16 year olds with T1DM (duration >1 year), attending paediatric diabetes outpatient clinics based in 4 centres in South-West England, UK, will be recruited to a randomised controlled trial of one to one sessions of CBT versus non-directive supportive counselling. Participants will attend up to 6 sessions (weekly) with either a CBT therapist or a counsellor, with 2 further sessions at 6 and 12 months. Follow up will continue for 12 months post intervention. HbA1c is the primary outcome measure. Psychological measures will also be measured.

Study Design

Study Type:
Interventional
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Randomised Controlled Trial of Cognitive Behaviour Therapy: Efficacy and Acceptability for Adolescents With Type 1 Diabetes.
Study Start Date :
Sep 1, 2001
Study Completion Date :
Jun 1, 2005

Outcome Measures

Primary Outcome Measures

  1. HBA1c []

Secondary Outcome Measures

  1. Well Being Questionnaire, Children's Health locus of control, []

  2. Diabetes Quality of Life for Youths (modified from DCCT), []

  3. Self Efficacy for Diabetes Scale (modified version,), []

  4. Diabetes Family Behaviour Scale, Diabetes Readiness to Change Questionnaire, []

  5. Modified Health Care Climate Questionnaire (at baseline only). []

Eligibility Criteria

Criteria

Ages Eligible for Study:
11 Years to 16 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Attendance at out-patients clinics at Bristol Royal Hospital for Children, Southmead Hospital in Bristol, Weston General Hospital, The Royal United Hospital in Bath, Gloucestershire Royal Hospital in Gloucester or the Musgrove Park branch of the Taunton and Somerset Hospital Aged 11-16 years old (inclusive) on the first day of the study Type 1 diabetes Duration at least 12 months on the first day of the study
Exclusion Criteria:
  • chronic illnesses with dietary management implications (e.g. cystic fibrosis and coeliac disease) special educational needs (e.g. Down's syndrome) making the patient unable to co-operate with CBT in care of social services primary responsibility for care elsewhere English not spoken as a first language Known psychological/ psychiatric problems for which the patient has already been referred

Contacts and Locations

Locations

Site City State Country Postal Code
1 Bristol Royal Hospital for Children Bristol United Kingdom BS2 8BJ

Sponsors and Collaborators

  • University of Bristol
  • Diabetes UK

Investigators

  • Principal Investigator: Elizabeth C Crowne, MD, UBHT
  • Study Chair: Ruth J Allen, PhD, University of Bristol

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
, ,
ClinicalTrials.gov Identifier:
NCT00360061
Other Study ID Numbers:
  • ECCRA/2001
  • DUK grant BDA: RD01/0002114
First Posted:
Aug 3, 2006
Last Update Posted:
Aug 3, 2006
Last Verified:
Jun 1, 2001

Study Results

No Results Posted as of Aug 3, 2006